Puma Biotechnology Inc (PBYI)
2.925
+0.08
(+2.99%)
USD |
NASDAQ |
Nov 21, 14:56
Puma Biotechnology Price: 2.925 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 2.74 | 2.86 | 2.66 | 2.84 | 270550.0 |
| Nov 19, 2024 | 2.72 | 2.76 | 2.54 | 2.74 | 371567.0 |
| Nov 18, 2024 | 2.45 | 2.75 | 2.32 | 2.74 | 686854.0 |
| Nov 15, 2024 | 3.01 | 3.01 | 2.35 | 2.42 | 1.537M |
| Nov 14, 2024 | 2.99 | 3.25 | 2.922 | 2.99 | 789425.0 |
| Nov 13, 2024 | 3.21 | 3.22 | 2.96 | 2.97 | 459660.0 |
| Nov 12, 2024 | 3.32 | 3.37 | 3.065 | 3.21 | 740257.0 |
| Nov 11, 2024 | 2.93 | 3.48 | 2.93 | 3.30 | 1.716M |
| Nov 08, 2024 | 3.39 | 3.51 | 2.83 | 2.88 | 1.450M |
| Nov 07, 2024 | 3.06 | 3.139 | 2.98 | 3.03 | 493372.0 |
| Nov 06, 2024 | 3.08 | 3.19 | 2.98 | 3.06 | 425115.0 |
| Nov 05, 2024 | 2.98 | 3.03 | 2.91 | 2.96 | 212939.0 |
| Nov 04, 2024 | 2.95 | 3.04 | 2.872 | 2.95 | 366379.0 |
| Nov 01, 2024 | 2.90 | 3.00 | 2.82 | 2.95 | 429645.0 |
| Oct 31, 2024 | 2.84 | 2.93 | 2.765 | 2.85 | 178695.0 |
| Oct 30, 2024 | 2.78 | 2.91 | 2.775 | 2.84 | 133951.0 |
| Oct 29, 2024 | 2.82 | 2.84 | 2.70 | 2.79 | 199947.0 |
| Oct 28, 2024 | 2.98 | 3.12 | 2.82 | 2.83 | 272134.0 |
| Oct 25, 2024 | 2.80 | 3.13 | 2.80 | 2.95 | 400578.0 |
| Oct 24, 2024 | 2.81 | 2.86 | 2.79 | 2.80 | 262932.0 |
| Oct 23, 2024 | 2.83 | 2.84 | 2.781 | 2.81 | 193296.0 |
| Oct 22, 2024 | 2.81 | 2.89 | 2.777 | 2.84 | 115173.0 |
| Oct 21, 2024 | 2.86 | 2.905 | 2.785 | 2.81 | 120072.0 |
| Oct 18, 2024 | 2.81 | 2.906 | 2.77 | 2.88 | 144700.0 |
| Oct 17, 2024 | 2.87 | 2.879 | 2.76 | 2.83 | 147903.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.64
Minimum
May 11 2022
14.56
Maximum
Feb 05 2020
5.835
Average
4.36
Median
Feb 17 2023
Price Benchmarks
| Pfizer Inc | 24.92 |
| NovaBay Pharmaceuticals Inc | 0.70 |
| Palatin Technologies Inc | 0.9146 |
| iBio Inc | 2.40 |
| Theriva Biologics Inc | 1.24 |
Price Related Metrics
| PE Ratio | 6.223 |
| PS Ratio | 0.5814 |
| PEG Ratio | 0.0128 |
| Price to Book Value | 2.020 |
| Price to Free Cash Flow | 4.205 |
| Earnings Yield | 16.07% |
| Market Cap | 143.58M |
| PEGY Ratio | 0.0128 |
| Operating PE Ratio | 4.371 |
| Normalized PE Ratio | 6.223 |